摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-isopentylbenzo[a]phenazin-5(7H)-one | 1335024-83-3

中文名称
——
中文别名
——
英文名称
6-isopentylbenzo[a]phenazin-5(7H)-one
英文别名
6-(3-methylbutyl)-7H-benzo[a]phenazin-5-one
6-isopentylbenzo[a]phenazin-5(7H)-one化学式
CAS
1335024-83-3
化学式
C21H20N2O
mdl
——
分子量
316.403
InChiKey
PFPLXBRPMYWPNK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.77
  • 重原子数:
    24.0
  • 可旋转键数:
    3.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    45.75
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

反应信息

  • 作为产物:
    描述:
    4-hydroxy-3-(3-methylbutyl)naphthalene-1,2-dione邻苯二胺sodium acetate溶剂黄146 作用下, 以90%的产率得到6-isopentylbenzo[a]phenazin-5(7H)-one
    参考文献:
    名称:
    Quinonoid and phenazine compounds: Synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis
    摘要:
    Several quinonoid and phenazine compounds were synthesized in moderate to high yields and showed activity against H(37)Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis. The cytotoxity of the compounds were evaluated against human peripheral blood mononuclear cells (PBMC) and these substances emerge as promising antitubercular prototypes. (C) 2011 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2011.07.026
点击查看最新优质反应信息

文献信息

  • Quinonoid and phenazine compounds: Synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis
    作者:Paula F. Carneiro、Maria do Carmo F.R. Pinto、Tatiane S. Coelho、Bruno C. Cavalcanti、Cláudia Pessoa、Carlos A. de Simone、Isabelle K.C. Nunes、Nathalia M. de Oliveira、Renata G. de Almeida、Antonio V. Pinto、Kelly C.G. de Moura、Pedro A. da Silva、Eufrânio N. da Silva Júnior
    DOI:10.1016/j.ejmech.2011.07.026
    日期:2011.9
    Several quinonoid and phenazine compounds were synthesized in moderate to high yields and showed activity against H(37)Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis. The cytotoxity of the compounds were evaluated against human peripheral blood mononuclear cells (PBMC) and these substances emerge as promising antitubercular prototypes. (C) 2011 Elsevier Masson SAS. All rights reserved.
查看更多